managerial accounting, The development of Demola and its open innovation approach has been further enhanced with its integration into the 'New Factory' platform which also includes Protomo and Suuntaamo as innovation approaches that respectively support the development of innovative ideas by entrepreneurs and business professionals and the engagement of citizens in innovation, product and service development. The establishment of Demola as a neutral ground location, not dependent on any one partner or university, has allowed flexibility in growth and has given confidence to potential new partners when joining. Running in a cost-efficient and agile manner has allowed quick reactions to changing environments and events.

Question 71 1. Is it safe to give piracetam to patients with primary intracerebral haemorrhage? Does it have a neuroprotective effect? 2. Is it safe to give a patient with excessively high blood pressure (as a sequela to recent primary intracerebral haemorrhage) angiotensin-converting enzyme inhibitors to lower the blood pressure? 3. Is it indicated to give piracetam or vincamine to a patient with middle cerebral artery territorial infarction? Do these have any neuroprotective effect?

Question 72 What is the mechanism by which subarachnoid haemorrhage is associated with subhyaloid haemorrhages on fundus examination, and how can cerebrospinal fluid (CSF) gain access to the subhyaloid space inside the eye?

Question 73 What is the recommended dosage for nimodipine given intravenously in cases of subarachnoid haemorrhage, and when should the treatment start? For how long should the dose be continued?

Question 74 I read recently that hyperuricaemia has something to do with stroke? Is it recommended to give allopurinol to stroke patients irrespective of their serum uric acid?

Question 75 Is there a link between hyperuricaemia (although asymptomatic) and atherosclerosis and cerebral ischaemic stroke?

Question 76 Are phenytoin and carbamazepine indicated in myoclonus, occasionally seen in ischemic strokes?

Question 77 What is the treatment of chorea or action myoclonus resulting from embolic stroke to the area of basal ganglia? Does the L-dopa that is given by some neurologists improve the condition? Does valproate have a role if the case is action myoclonus?

Question 78 How should a patient with a haemorrhagic cerebrovascular accident be managed while also having an extensive inferior wall myocardial infarction?

Question 79 What is the best way to manage cortical vein thrombosis? If heparin is to be used, what is the recommended dosage and how long should this treatment last?

Question 80 In the case of cortical vein thrombosis, for how long should anticoagulation be continued?